C12N 9/6497
Endothelin-converting enzyme
Official title: {Endothelin-converting enzyme (3.4.24.71)}
C12N9/6497 (Endothelin-converting enzyme) appears on 17 US grants and 12 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 12
- Assignees
- 12
- Inventors
- 29
- Latest grant
- 5 Mar 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 2 | 1 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 2 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Screening and treatment methods using IGS5 enzymes of the metalloprotease family5 Mar 2013US 8,389,284 B2Abbott Healthcare Products B.V.
- Screening and treatment methods using IGS5 enzymes of the metalloprotease family6 Sep 2011US 8,012,471 B2Abbott Healthcare Products B.V.
- Antibody to human enzymes of the metalloprotease family25 Dec 2007US 7,312,321 B2Solvay Pharmaceuticals GmbH
- Human enzymes of the metalloprotease family13 Mar 2007US 7,189,525 B2Solvay Pharmaceuticals GmbH
- Human enzymes of the metalloprotease family1 Aug 2006US 7,083,965 B2Solvay Pharmaceuticals GmbH
- Therapeutic induction of tolerance using recombinant cell surface antigens7 Oct 2021US 2021/0308239 A1Bloodworks
- Therapeutic induction of tolerance using recombinant cell surface antigens14 Feb 2019US 2019/0046620 A1Bloodworks
- Screening and Treatment Methods Using IGS5 Enzymes of the Metalloprotease Family27 Oct 2011US 2011/0262930 A1Abbott Healthcare Products B.V.
- Novel Human Enzymes of the Metalloprotease Family20 Mar 2008US 2008/0070259 A1Solvay Pharmaceuticals GmbH
- Screening and treatment methods using IGS5 enzymes of the metalloprotease family27 Sep 2007US 2007/0224180 A1Solvay Pharmaceuticals GmbH
Most cited
By later US patents
- Method of converting big endothelin-1 to endothelin-1 with human apolipoprotein B7US 5,468,623 ANisshin Flour Milling Co., Ltd. · 1995
- Human enzymes of the metalloprotease family6US 7,189,525 B2Solvay Pharmaceuticals GmbH · 2007
- Human endothelin converting enzyme isolated from blood or placenta by hydrated density4US 5,462,869 ANisshin Flour Milling Co., Ltd. · 1995
- Methods of screening of effectors of endothelin converting enzyme-14US 5,688,640 ABoard of Regents, The University of Texas System · 1997
- Recombinant endothelin converting enzyme-2 and its use in ECE inhibitor screening4US 5,736,376 ABoard of Regents, The University of Texas System · 1998